View in EDS PDF Full Text

Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.

Saved in:
Bibliographic Details
Title: Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
Authors: Bergman DR; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States., Wang Y; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States., Trujillo E; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Fernald AA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Li L; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Pearson AT; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Sweis RF; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Jackson TL; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Mar 07; Vol. 15, pp. 1358019. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1358019